Equanil and Occipital neuralgia - a phase IV clinical study of FDA data
We study 2,292 people who take Equanil or have Occipital neuralgia. No report of Occipital neuralgia is found in people who take Equanil.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Equanil?
Equanil has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 1,242 Equanil users for its effectiveness, alternative drugs and more.
What is Occipital Neuralgia?
Occipital neuralgia (condition characterized by chronic pain in the upper neck) is found to be associated with 680 drugs and 372 conditions by eHealthMe.
Do you take Equanil and have Occipital neuralgia?Check whether Occipital neuralgia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Occipital neuralgia and when was it recovered:
Expand to all the drugs that have ingredients of meprobamate:
Alternative drugs to, pros and cons of Equanil:
- Equanil (1,242 reports)
Occipital neuralgia treatments and more:
- Occipital neuralgia (1,050 reports)
COVID vaccines that are related to Occipital neuralgia:
- Occipital neuralgia in Moderna COVID Vaccine
- Occipital neuralgia in Pfizer BioNTech Covid Vaccine
- Occipital neuralgia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Occipital neuralgia:
All the conditions that are associated with Occipital neuralgia:
How the study uses the data?
The study uses data from the FDA. It is based on meprobamate (the active ingredients of Equanil) and Equanil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- L-Methylfolate vs. St. John'S Wort - a second ago
- Peg-Intron and Hepatic Steatosis - 2 seconds ago
- Neoral and Blister - 3 seconds ago
- Naproxen and Aortic Elongation - 7 seconds ago
- Ramipril and Skin Swelling - 11 seconds ago
- Vigamox and Uveitis - 11 seconds ago
- Potassium Chloride and Posture Abnormal - 13 seconds ago
- Lisinopril and Arterial Catheterisation Abnormal - 13 seconds ago
- Kesimpta and Hypotension - 17 seconds ago
- Octreotide Acetate and Psoriasis Aggravated - 18 seconds ago